Cargando…

1156. Clinical and epidemiological features and outcomes of Blastomycosis in a tertiary hospital in Kentucky

BACKGROUND: Blastomycosis is an endemic dimorphic fungal infection caused by Blastomyces dermatitidis. The risk factors associated with severe presentation are not well defined. METHODS: Retrospective study of patients treated for blastomycosis at the University of Kentucky Hospital from 2004-2019....

Descripción completa

Detalles Bibliográficos
Autores principales: Cari, Evelyn Villacorta, Leedy, Nicole, Ribes, Julie A, Soria, Jaime, Myint, Thein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777301/
http://dx.doi.org/10.1093/ofid/ofaa439.1342
_version_ 1783630870550151168
author Cari, Evelyn Villacorta
Leedy, Nicole
Ribes, Julie A
Soria, Jaime
Myint, Thein
author_facet Cari, Evelyn Villacorta
Leedy, Nicole
Ribes, Julie A
Soria, Jaime
Myint, Thein
author_sort Cari, Evelyn Villacorta
collection PubMed
description BACKGROUND: Blastomycosis is an endemic dimorphic fungal infection caused by Blastomyces dermatitidis. The risk factors associated with severe presentation are not well defined. METHODS: Retrospective study of patients treated for blastomycosis at the University of Kentucky Hospital from 2004-2019. Statistical analyses were performed with STATA version 12.0 (College Station, Texas). Logistic regression was used to identify variables associated with severe infections. RESULTS: Among 82 patients, median age was 48 years old (range: 16 - 89); 66 (80.5%) were male and 71 (92.2%) were white, 25/77 (32.4%) were obese, 24 (29.2%) were diabetic, 21 (25.6%) had COPD, 26 (31.7%) had at least one immunosuppressive condition. The median duration of illness was 86 (3-365) days. 37 (45.1%) had cough and 35 (42.6%) had dyspnea 19 (23.1%) patients were treated in the ICU, 42 (51.3%) in non-ICU inpatient wards, and 21 (25.6%) in an outpatient setting. Cultures were obtained in 69 cases, 59 (85.5%) reported as positive, KOH stain positive in 30/61 (49.1%). Histopathology was positive in 48/66 (72.7%) samples. Urine Histoplasma or Blastomyces antigen was positive in 41/58 (70.6%), and Serum Histoplasma or Blastomyces antigen was positive in 22/34 (64.7%). Among 64 (78.0%) patients with pulmonary blastomycosis, acute and chronic pneumonia were 16 (25.0%) and 12 (18.7%) cases respectively, and nodular lung lesions were reported in 36 (56.2%). Initial antifungal treatment was amphotericin B liposomal in 38/80 (47.5%), overall mortality was 11 (13.4%). A multivariable analysis was performed to find predictors of severe blastomycosis infection, no association was seen with factors as male sex (IRR 1.96; 95%CI 0.84 – 4.55), and was confirmed that significant independent associated risk factors for severe infection were age older than 50 (IRR 3.5; 95%CI 1.42-8.83), obesity (IRR 3.1; 95% CI 1.41-6.87), diabetes (IRR 2.5; 95% CI 1.16-5.50), leukocytosis (IRR 1.03; 95%CI 1.00-1.07) and anemia (IRR 3.0; 95% CI 1.55-5.85). CONCLUSION: Pulmonary Blastomycosis is the most common presentation. Culture and histopathology are more sensitive than antigen assay. Independent factors associated to severe disease were older age, obesity, diabetes, and anemia at admission. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-7777301
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-77773012021-01-07 1156. Clinical and epidemiological features and outcomes of Blastomycosis in a tertiary hospital in Kentucky Cari, Evelyn Villacorta Leedy, Nicole Ribes, Julie A Soria, Jaime Myint, Thein Open Forum Infect Dis Poster Abstracts BACKGROUND: Blastomycosis is an endemic dimorphic fungal infection caused by Blastomyces dermatitidis. The risk factors associated with severe presentation are not well defined. METHODS: Retrospective study of patients treated for blastomycosis at the University of Kentucky Hospital from 2004-2019. Statistical analyses were performed with STATA version 12.0 (College Station, Texas). Logistic regression was used to identify variables associated with severe infections. RESULTS: Among 82 patients, median age was 48 years old (range: 16 - 89); 66 (80.5%) were male and 71 (92.2%) were white, 25/77 (32.4%) were obese, 24 (29.2%) were diabetic, 21 (25.6%) had COPD, 26 (31.7%) had at least one immunosuppressive condition. The median duration of illness was 86 (3-365) days. 37 (45.1%) had cough and 35 (42.6%) had dyspnea 19 (23.1%) patients were treated in the ICU, 42 (51.3%) in non-ICU inpatient wards, and 21 (25.6%) in an outpatient setting. Cultures were obtained in 69 cases, 59 (85.5%) reported as positive, KOH stain positive in 30/61 (49.1%). Histopathology was positive in 48/66 (72.7%) samples. Urine Histoplasma or Blastomyces antigen was positive in 41/58 (70.6%), and Serum Histoplasma or Blastomyces antigen was positive in 22/34 (64.7%). Among 64 (78.0%) patients with pulmonary blastomycosis, acute and chronic pneumonia were 16 (25.0%) and 12 (18.7%) cases respectively, and nodular lung lesions were reported in 36 (56.2%). Initial antifungal treatment was amphotericin B liposomal in 38/80 (47.5%), overall mortality was 11 (13.4%). A multivariable analysis was performed to find predictors of severe blastomycosis infection, no association was seen with factors as male sex (IRR 1.96; 95%CI 0.84 – 4.55), and was confirmed that significant independent associated risk factors for severe infection were age older than 50 (IRR 3.5; 95%CI 1.42-8.83), obesity (IRR 3.1; 95% CI 1.41-6.87), diabetes (IRR 2.5; 95% CI 1.16-5.50), leukocytosis (IRR 1.03; 95%CI 1.00-1.07) and anemia (IRR 3.0; 95% CI 1.55-5.85). CONCLUSION: Pulmonary Blastomycosis is the most common presentation. Culture and histopathology are more sensitive than antigen assay. Independent factors associated to severe disease were older age, obesity, diabetes, and anemia at admission. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2020-12-31 /pmc/articles/PMC7777301/ http://dx.doi.org/10.1093/ofid/ofaa439.1342 Text en © The Author 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Poster Abstracts
Cari, Evelyn Villacorta
Leedy, Nicole
Ribes, Julie A
Soria, Jaime
Myint, Thein
1156. Clinical and epidemiological features and outcomes of Blastomycosis in a tertiary hospital in Kentucky
title 1156. Clinical and epidemiological features and outcomes of Blastomycosis in a tertiary hospital in Kentucky
title_full 1156. Clinical and epidemiological features and outcomes of Blastomycosis in a tertiary hospital in Kentucky
title_fullStr 1156. Clinical and epidemiological features and outcomes of Blastomycosis in a tertiary hospital in Kentucky
title_full_unstemmed 1156. Clinical and epidemiological features and outcomes of Blastomycosis in a tertiary hospital in Kentucky
title_short 1156. Clinical and epidemiological features and outcomes of Blastomycosis in a tertiary hospital in Kentucky
title_sort 1156. clinical and epidemiological features and outcomes of blastomycosis in a tertiary hospital in kentucky
topic Poster Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777301/
http://dx.doi.org/10.1093/ofid/ofaa439.1342
work_keys_str_mv AT carievelynvillacorta 1156clinicalandepidemiologicalfeaturesandoutcomesofblastomycosisinatertiaryhospitalinkentucky
AT leedynicole 1156clinicalandepidemiologicalfeaturesandoutcomesofblastomycosisinatertiaryhospitalinkentucky
AT ribesjuliea 1156clinicalandepidemiologicalfeaturesandoutcomesofblastomycosisinatertiaryhospitalinkentucky
AT soriajaime 1156clinicalandepidemiologicalfeaturesandoutcomesofblastomycosisinatertiaryhospitalinkentucky
AT myintthein 1156clinicalandepidemiologicalfeaturesandoutcomesofblastomycosisinatertiaryhospitalinkentucky